Rosecrance Therapies

What the SAMHSA Record Shows About Rosecrance Therapies

Rosecrance Therapies is a substance use treatment operated by Private non-profit organization in Chicago, Illinois. The facility's N-SUMHSS record lists 2 primary care modalities (outpatient, telehealth), which shapes both how treatment is delivered and how intake is scheduled. Medication-Assisted Treatment (MAT) is reported as available, meaning FDA-approved medications such as methadone, buprenorphine, or naltrexone may be combined with counseling for opioid or alcohol use disorder. The full postal address on file is 320 West Ohio Street, Suite 410-E, Chicago, IL 60654.

On the services side, the facility self-reports 9 distinct service lines (Cognitive behavioral therapy, Intensive outpatient, Medication-assisted treatment (MAT), Mental health services, Motivational interviewing, Outpatient, Substance use treatment, Suicide prevention services, Telehealth), 3 substance or condition categories treated (Alcohol, General substance use disorders, Opioids), and 6 clinical treatment approaches (Cognitive behavioral therapy, Matrix Model, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy). It serves 1 specific population group (Adolescents) with 1 language of care (Sign language services for the deaf and hard of hearing). Those figures give a rough signal of programmatic breadth, a higher number of approaches and populations usually indicates more structured clinical programming rather than a single-modality operation. Payment-wise, the record confirms Medicaid, Medicare, private insurance, plus 5 specific payment methods enumerated in the survey (Cash or self-payment, Federal, or any government funding for substance use treatment programs, Medicaid, Medicare, Private health insurance).

Rosecrance Therapies reports 26 attributes across services, populations, payment, and language, in line with the Illinois statewide median of 31 (745 facilities listed).

Use this page as a starting screen, not a final decision. SAMHSA fields are self-reported by the facility and refreshed on a rolling basis, so wait times, bed availability, current insurance contracts, and staff credentials are best confirmed on a direct intake call to (815) 391-1000. This page is a factual directory summary, not medical advice, clinical endorsement, or a guarantee of admission. For any acute crisis or active substance-use emergency, call the SAMHSA National Helpline at 1-800-662-4357 or the 988 Suicide & Crisis Lifeline before visiting any facility.